The operative mortality of valve replacement has today dropped to a level that depends largely on the state of the patient's myocardium at the time of surgery and the pulmonary vascular resistance. Interest is, therefore, being increasingly directed towards the late complications of valve replacement, a study made difficult by the fact that individual cardiac units frequently change their valve replacement technique. When a new valve is introduced, there is a gradation over two years from enthusiasm to doubt and then to abandonment or modification of the original valve. This has been true of homografts, heterografts, and prosthetic valves and applies to the series reported here.
At St. Thomas' Hospital we elected to use Starr valves only for valve replacements, starting with the last of the models with the Silastic ball and metal strut valve in I965, and changing to the cloth-covered valve with a metal ball when that became available in January i968. Starr-Edwards ball valve prostheses have been used in all patients requiring valve replacement except for 3 young patients who had homograft and autograft replacements. This series is not therefore selected, as many homograft series are, where the worst risk and most ill patients receive prosthetic valves because of the shorter length of time required for their insertion compared with homografts.
The long-term complication of prosthetic valve replacement that causes most concern Received 27 April 1970. is thromboembolism, which can in this series be assessed easily because it deals with the last 4 years only and because the type of valve was changed only once. Long-term evaluation is not therefore loaded with complications due to the early and less satisfactory models which produced the often quoted statement from Starr's early series that half his late deaths in isolated mitral valve replacement were due to thromboembolism (Starr, Herr, and Wood, I967) . In this series a diagnosis of embolism was made if there had been any symptom or sign that could possibly be interpreted as embolic. In this way it was hoped to include every possible embolus.
One hundred and six patients who had undergone Starr valve replacement form the basis of this study. The details of the surgical procedure are shown in Table i One-half of the patients had cloth-covered valves. They have now been followed for a period of 6 months to 4 years. Twenty-two of these have been followed for more than 2 years, 5 from I to 2 years, 9 for 6 months to i year, and IO for less than 6 months.
Five patients have died, 2 from dehiscence of the valve from heavily calcified aortic rings, 2 from arrhythmias, and one from myocardial failure.
No patient at necropsy had evidence of thrombosis on the prosthetic valves. There has been no systemic embolism or valve failure in this group, though 7 per cent have developed minor regurgitant murmurs.
Mitral valve replacement (Table 3) Thirty-one patients were discharged home after successful replacement of their mitral There has been one late death 5 months after operation due to multiple embolic episodes.
A 35-year-old woman had a silastic ball triple valve replacement in April i967. When seen in the outpatient clinic two months later she could walk easily and lie flat. Her condition was recorded as 'absolutely marvellous'. A week later she was admitted with a history of abdominal pain and in June she had a cerebrovascular accident leading to hemiplegia. She was recovering from it satisfactorily, but then in August had an attack of grand mal, became unconscious, and died five days later. At necropsy the giant left atrium was found to contain much thrombus but the prosthetic valves were free of thrombus. There were infarcts in the cerebellum and in the spleen.
Discussion
Anticoagulants are necessary after prosthetic valve replacement for at least a year. The role of anticoagulants in reducing the formation of thrombi on prosthetic valves is convincing, as the incidence of embolic phenomena is high in series where anticoagulants were not used. Gadboys from the Mount Sinai Clinic in a mixed series has reported the incidence of embolism to be 5 per cent when anticoagulants were used and 44 per cent when they were not (Gadboys et 
